<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: CHING CHOON HWA -->
          <cik>0002078320</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Ordinary shares, $0.51 per Ordinary Share and associated Warrants</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>07/29/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001723980</issuerCik>
        <issuerName>China SXT Pharmaceuticals, Inc.</issuerName>
        <issuerCusip>G2161P157</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>178 TAIDONG ROAD NORTH</com:street1>
          <com:city>TAIZHOU</com:city>
          <com:stateOrCountry>F4</com:stateOrCountry>
          <com:zipCode>225300</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>CHING CHOON HWA</reportingPersonName>
      <citizenshipOrOrganization>U0</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>9803920.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>9803920.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>9803920.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>8.45</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>Percentage of class is calculated based on 116,027,758 Ordinary Shares outstanding as of July 29, 2025, which information was provided by the Issuer to the Reporting Person on July 29, 2025. Given that as of July 29, 2025, the Issuer has 116,027,758 Ordinary Shares outstanding, comprising 116,027,226 Class A Ordinary Shares, each entitled to one vote, and 532 Class B Ordinary Shares, each entitled to fifty votes, the total voting power of the Issuer is 116,053,826 votes. The Reporting Person holds 9,803,920 Class A Ordinary Shares, representing approximately 8.45% of the total voting power of the Issuer.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>China SXT Pharmaceuticals, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>178 TAIDONG ROAD NORTH, TAIZHOU F4 225300</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>CHING CHOON HWA</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Blk 695 Jurong West Central 1 #09-41 Singapore 640695</principalBusinessOfficeOrResidenceAddress>
        <citizenship>SINGAPORE/U0</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>9,803,920</amountBeneficiallyOwned>
        <classPercent>8.45%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>9,803,920</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>9,803,920</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>N</notApplicableFlag>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>CHING CHOON HWA</reportingPersonName>
      <signatureDetails>
        <signature>/s/ CHING CHOON HWA</signature>
        <title>CHING CHOON HWA</title>
        <date>08/07/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
